NH SPAC 2 - Asset Resilience Ratio

Latest as of December 2025: 6.45%

NH SPAC 2 (206640) has an Asset Resilience Ratio of 6.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩18.17 Billion

≈ $12.31 Million USD Cash + Short-term Investments

Total Assets

₩281.63 Billion

≈ $190.86 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how NH SPAC 2's Asset Resilience Ratio has changed over time. Check NH SPAC 2 PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down NH SPAC 2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 206640 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩18.17 Billion	6.45%
Total Liquid Assets	₩18.17 Billion	6.45%

Asset Resilience Insights

Limited Liquidity: NH SPAC 2 maintains only 6.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

NH SPAC 2 Industry Peers by Asset Resilience Ratio

Compare NH SPAC 2's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Bio-Rad Laboratories Inc NYSE:BIO	Medical Devices	10.80%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Imricor Medical Systems Inc AU:IMR	Medical Devices	46.50%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for NH SPAC 2 (2015–2025)

The table below shows the annual Asset Resilience Ratio data for NH SPAC 2.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.45%	₩18.17 Billion ≈ $12.31 Million	₩281.63 Billion ≈ $190.86 Million	-17.78pp
2024-12-31	24.23%	₩61.71 Billion ≈ $41.82 Million	₩254.67 Billion ≈ $172.59 Million	-9.20pp
2023-12-31	33.43%	₩76.20 Billion ≈ $51.64 Million	₩227.90 Billion ≈ $154.45 Million	+2.54pp
2022-12-31	30.89%	₩60.44 Billion ≈ $40.96 Million	₩195.66 Billion ≈ $132.59 Million	-4.72pp
2021-12-31	35.61%	₩68.45 Billion ≈ $46.39 Million	₩192.24 Billion ≈ $130.28 Million	-0.08pp
2020-12-31	35.68%	₩58.34 Billion ≈ $39.53 Million	₩163.47 Billion ≈ $110.78 Million	+14.27pp
2019-12-31	21.42%	₩21.69 Billion ≈ $14.70 Million	₩101.26 Billion ≈ $68.62 Million	-3.51pp
2018-12-31	24.93%	₩25.79 Billion ≈ $17.47 Million	₩103.44 Billion ≈ $70.10 Million	+1.63pp
2017-12-31	23.30%	₩25.20 Billion ≈ $17.08 Million	₩108.17 Billion ≈ $73.30 Million	+8.25pp
2016-12-31	15.05%	₩13.67 Billion ≈ $9.26 Million	₩90.79 Billion ≈ $61.53 Million	+5.49pp
2015-12-31	9.56%	₩6.86 Billion ≈ $4.65 Million	₩71.71 Billion ≈ $48.59 Million	--

pp = percentage points

About NH SPAC 2

KQ:206640 Korea Medical Devices

Market Cap

$167.83 Million

₩247.65 Billion KRW

Market Cap Rank

#17158 Global

#652 in Korea

Share Price

₩11550.00

Change (1 day)

+7.34%

52-Week Range

₩9800.00 - ₩14800.00

All Time High

₩36222.75